SenesTech Announces Bradley Caldwell, Inc. as New U.S. Distributor for Evolve Rodent Fertility Control Products
- Partnership with BCI provides access to over 8,000 farm, ranch, hardware, and pet supply dealers nationwide
- Received largest distributor stocking order in company history from BCI
- Strategic expansion into underserved rural markets where traditional rodenticides face resistance
- Enhanced distribution network targeting agricultural communities with high rodent control needs
- None.
Insights
SenesTech secures major distribution deal with Bradley Caldwell to expand Evolve rodent control access across rural America, boosting market reach significantly.
SenesTech's new distribution agreement with Bradley Caldwell, Inc. (BCI) represents a strategic expansion that significantly enhances the company's commercial footprint. BCI's network of over 8,000 farm, ranch, hardware, and pet supply dealers provides SenesTech with unprecedented access to rural markets where rodent control is particularly critical.
This partnership offers several key advantages for SenesTech:
- BCI's extensive rural retail penetration allows Evolve products to reach previously underserved agricultural communities
- The deal accelerates SenesTech's go-to-market strategy by leveraging BCI's established logistics infrastructure
- BCI placed the largest distributor stocking order in SenesTech's history, providing immediate revenue impact
The agreement addresses a fundamental challenge for specialty product manufacturers: building efficient distribution channels. By partnering with an established wholesale distributor founded in 1930, SenesTech gains immediate credibility with rural retailers who might otherwise hesitate to stock innovative alternatives to traditional rodenticides.
For context, the rural and agricultural pest control market represents a substantial opportunity, as rodent infestations cause billions in agricultural damage annually. SenesTech's fertility control approach provides these markets with a differentiated solution where traditional poisons face increasing regulatory scrutiny and resistance issues.
This partnership aligns with SenesTech's broader commercialization roadmap, potentially accelerating revenue growth by expanding both geographic reach and market penetration in key agricultural segments where rodent control is essential for protecting crops, feed, and infrastructure.
Strategic Partnership Expands National Reach and Accelerates Retail & Dealer Access Across Rural America
"Bradley Caldwell is an ideal partner to help us scale Evolve's presence in core markets where rodent infestations are not only common, but extremely costly," said Joel Fruendt, CEO of SenesTech. "Their trusted relationships and deep penetration into rural retail channels align perfectly with our mission to provide safe, effective, and sustainable rodent control to every corner of the country."
Founded in 1930 and headquartered in
Strategic Benefits to SenesTech and BCI Customers:
- Accelerated Market Penetration: Evolve will now be more accessible in underserved markets where traditional rodenticides face resistance or regulatory limits.
- Product Differentiation: BCI customers can offer a scientifically-backed, humane alternative to poison – enhancing their competitive edge.
- Sales Momentum: This partnership supports SenesTech's long-term growth strategy, with anticipated revenue increases from expanded retail sales and new customer acquisition.
This agreement underscores SenesTech's continued execution on its channel expansion and commercialization roadmap, making Evolve a widely available, easy-to-deploy solution in both professional and consumer markets.
BCI's initial order represents the largest distributor stocking order the Company has received.
About SenesTech
We are committed to improving the health of the world by humanely managing animal pest populations through our expertise in fertility control. We invented ContraPest®, the only
For more information visit https://senestech.com/.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our belief that the new partnership with BCI expands our national distribution footprint and brings Evolve Rodent Birth Control directly to the hands of rural retailers and independent dealers who serve America's agricultural communities; our belief that Bradley Caldwell is an ideal partner to help us scale Evolve's presence in core markets where rodent infestations are not only common, but extremely costly; our belief that BCI's trusted relationships and deep penetration into rural retail channels align perfectly with our mission to provide safe, effective, and sustainable rodent control to every corner of the country; our belief that Evolve will now be more accessible in underserved markets; our belief that the partnership with BCI supports our long-term growth strategy, with anticipated revenue increases from expanded retail sales and new customer acquisition; and our belief that the BCI agreement underscores our continued execution on our channel expansion and commercialization roadmap, making Evolve a widely available, easy-to-deploy solution in both professional and consumer markets. Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products, market acceptance of our products, regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.
Contact Information:
Investors:
Robert Blum, Lytham Partners, LLC
(602) 889-9700
senestech@lythampartners.com
Marketing:
Rochelle Paulet, Director of Marketing, SenesTech, Inc.
(928) 779-4143 x814
View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-announces-bradley-caldwell-inc-as-new-us-distributor-for-evolve-rodent-fertility-control-products-302478092.html
SOURCE SenesTech, Inc.
FAQ
What is the significance of SenesTech's partnership with Bradley Caldwell for SNES stock?
How will the Bradley Caldwell distribution agreement affect SenesTech's market presence?
What products will Bradley Caldwell distribute for SenesTech (SNES)?
What is Bradley Caldwell's reach as a distributor for SNES products?
When did SenesTech announce its distribution agreement with Bradley Caldwell?
